Vascular surgery: operating on patients on clopidogrel or warfarin

National Confidential Enquiry into Patient Outcome and Death. Abdominal Aortic Aneurysm, a Service in Need of Surgery? London: NCEPOD, 2005

Asciutto G , Geier B , Marpe B , Hummel T , Mumme A . Dacron patch infection after carotid angioplasty. A report of 6 cases. Eur J Vasc Endovasc Surg 2007; 33: 55–7

EVAR trial participants. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet. 2005; 365: 2179–86

Gohlke-Bärwolf C . Anticoagulation in valvar heart disease: new aspects and management during non-cardiac surgery. Heart 2000; 84: 567–72

Gage BF , Waterman AD , Shannon W , Validation of clinical classification schemes for predicting stroke. Results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864–70

Cannegieter SC , Rosendaal FR , Briët E . Thromboembolic and bleeding complications in patients with mechanical heart valve prosthesis. Circulation 1994; 89: 635–41

Dunn AS , Turpie AG . Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003; 163: 901–8

Katholi RE , Nolan SP , McGuire LB . Living with prosthetic heart valves. Subsequent noncardiac operations and the risk of thromboembolism or hemorrhage. Am Heart J 1976; 92: 162–7

Caliendo FJ , Halpern VJ , Marini CP , Warfarin anticoagulation in the perioperative period: is it safe? Ann Vasc Surg 1999; 13: 11–16

Steinbuhl SR , Berger PB , Mann JT , Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. A randomized trial (CREDO). JAMA 2002; 288: 2411–20

Vicenzi MN , Meislitzer T , Heitzinger B , Coronary artery stenting and non-cardiac surgery – a prospective outcome study. Br J Anaesth 2006; 96: 686–93

Mehta SR , Yusuf S , Peters RJ , Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527–33

Kaluza GL , Joseph J , Lee JR , Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35: 1288–94

Wilson SH , Fasseas P , Orford JL , Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol 2003; 42: 234–40

Compton PA , Zankar AA , Adesanya AO , Banerjee S , Brilakis ES . Risk of noncardiac surgery after coronary drug-eluting stent implantation. Am J Cardiol. 2006; 98: 1212–13

Beattie WS , Badner NH , Choi P . Epidural analgesia reduces postoperative myocardial infarction: a meta-analysis. Anesth Analg 2001; 93: 853–8

Pfisterer M , Brunner-La Rocca HP , Buser PT , ; BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 2006; 48: 2584–91

Eisenstein EL , Anstrom KJ , Kong DF , Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007; 297: 159–68

Grines CL , Bonow RO , Casey DE Jr , ; American Heart Association; American College of Cardiology; Society for Cardiovascular Angiography and Interventions; American College of Surgeons; American Dental Association; American College of Physicians. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. J Am Coll Cardiol 2007; 49: 734–9

Heeschen C , Hamm CW , Laufs U , Withdrawal of statins increases event rates in patient with acute coronary syndromes. Circulation 2002; 105: 1446–52

Goldman S , Copeland J , Moritz T , Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study. Circulation 1988; 77: 1324–32

Goldman S , Copeland J , Moritz T , Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group. Circulation 1991; 84: 520–6

Covin R , O'Brien M , Grunwald G , Factors affecting transfusion of fresh frozen plasma, platelets, and red blood cells during elective coronary artery bypass graft surgery. Arch Pathol Lab Med 2003; 127: 415–23

Srinivasan AK , Grayson AD , Pullan DM , Fabri BM , Dihmis WC . Effect of preoperative aspirin use in off-pump coronary artery bypass operations. Ann Thorac Surg 2003; 76: 41–5

Neilipovitz DT , Bryson GL , Nichol G . The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 2001; 93: 573–80

Chassot PG , Delabays A , Spahn DR . Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007; 99: 316–28

Ascione R , Ghosh A , Rogers CA , Cohen A , Monk C , Angelini GD . In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: a word of caution. Ann Thorac Surg 2005; 79: 1210–16

Hongo RH , Ley J , Dick SE , Yee RR . The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 2002; 40: 231–7

Kapetanakis EI , Medlam DA , Boyce SW , Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache? Eur Heart J 2005; 26: 576–83

Chu MW , Wilson SR , Novick RJ , Stitt LW , Quantz MA . Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004; 78: 1536–41

Englberger L , Faeh B , Berdat PA , Eberli F , Meier B , Carrel T . Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg 2004; 26: 96–101

Burger W , Chemnitius JM , Kneissl GD , Rücker G . Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its preoperative withdrawal versus bleeding risks with its continuation – review and meta-analysis. J Int Med 2005; 257: 399–414